1-5 of 5
Scott A Ely, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combination Of Palbociclib Plus Bortezomib Is Safe and Active In Patients With Previously Treated Mantle Cell Lymphoma: Final Results Of a Phase I Trial

Peter Martin, MD, Maurizio DiLiberto, PhD, Christopher E Mason, PhD, Scott A Ely, M.D., Jia Ruan, MD, PhD, Richard R. Furman, MD, David Chiron, PhD, Xiangao Huang, PhD, David C Madoff, M.D., Jonathan Navi, Jessica Lewis, PA-C, Alison Bender, PA-C, Amelyn Rodriguez, RN, June Greenberg, RN, Morton Coleman, MD, Selina Chen-Kiang, PhD, John P. Leonard, M.D.
Journal: Blood
Blood (2013) 122 (21): 4393.
https://doi.org/10.1182/blood.V122.21.4393.4393
Published: 2013
Journal Articles

Mutation Burden in CDKN2C, CDK1 and E2F2 Is Associated with Differential Response to Targeting CDK4/CDK6 in Combination with Bortezomib in Mantle Cell Lymphoma,

Christopher E. Mason, PhD, Maurizio Di Liberto, Ph.D., Xiangao Huang, PhD, David Chiron, PhD, Jamieson Bretz, Ph.D., Ramsey Abdallah, B.S., Scott A Ely, M.D., Daniel M Knowles, MD, Peter Martin, MD, John P. Leonard, MD, Selina Chen-Kiang, PhD
Journal: Blood
Blood (2011) 118 (21): 3738.
https://doi.org/10.1182/blood.V118.21.3738.3738
Published: 2011
Journal Articles

Bim Is Required to Sensitize Mantle Cell Lymphoma Cells for Killing by Bortezomib, but Not Ara-C, by Selective Inhibition of CDK4/CDK6

Xiangao Huang, PhD, Maurizio Di Liberto, Ph.D., Jamieson Bretz, Ph.D., David Chiron, PhD, Peter Martin, MD, Morton Coleman, MD, Jia Ruan, MD, PhD, Mitchell R Smith, MD, PhD, Scott A Ely, M.D., Christopher E. Mason, PhD, Phoebe Joy Ho, MBBS, DPhil, John P. Leonard, MD, Selina Chen-Kiang, PhD
Journal: Blood
Blood (2011) 118 (21): 1655.
https://doi.org/10.1182/blood.V118.21.1655.1655
Published: 2011
Journal Articles

Preliminary Results of a Phase 2 Study of PD 0332991 in Combination with Bortezomib and Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma

Ruben Niesvizky, MD, Luciano J Costa, MD, PhD, Nisreen A. Haideri, MD, Georg Hess, Seema Singhal, MD, Ivan Spicka, MD, PhD, Edward A. Stadtmauer, MD, Ashraf Z. Badros, MD, Marc S Raab, John L Jakubczak, PhD, Sindy T. Kim, BS, Sophia Randolph, MD, PhD, Scott A Ely, M.D., Selina Chen-Kiang, PhD
Journal: Blood
Blood (2011) 118 (21): 2940.
https://doi.org/10.1182/blood.V118.21.2940.2940
Published: 2011
Journal Articles

Induction of Metabolic Impairment In Prolonged Early G1 Arrest Induced by CDK4/CDK6 Inhibition Sensitizes Myeloma Cells for Proteasome Inhibitor Killing During Subsequent S Phase Synchronization

Maurizio Di Liberto, Ph.D., Xiangao Huang, Ph.D., Jamieson Bretz, Ph.D., Scott A Ely, M.D., Rediet Zewdu, B.S., David Jayabalan, B.S.M.S, Suzhen Chen, B.S., Christopher J Kirk, Ph.D., Sophia Randolph, M.D., Ph.D., Ruben Niesvizky, M.D., Ph.D., Selina Chen-Kiang, Ph.D.
Journal: Blood
Blood (2010) 116 (21): 2989.
https://doi.org/10.1182/blood.V116.21.2989.2989
Published: 2010